Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study
Livio Pagano, Caterina Giovanna Valentini, Alessandro Pulsoni, et al.
Haematologica (2012) Vol. 98, Iss. 2, pp. 239-246
Open Access | Times Cited: 305

Showing 26-50 of 305 citing articles:

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapy
Uday Deotare, Karen Yee, Lisa W. Le, et al.
American Journal of Hematology (2015) Vol. 91, Iss. 3, pp. 283-286
Open Access | Times Cited: 68
Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm
Narittee Sukswai, Phyu P. Aung, C. Cameron Yin, et al.
The American Journal of Surgical Pathology (2019) Vol. 43, Iss. 10, pp. 1429-1437
Closed Access | Times Cited: 68
Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm
Naveen Pemmaraju, Marina Konopleva
Blood Advances (2020) Vol. 4, Iss. 16, pp. 4020-4027
Open Access | Times Cited: 58
Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients
Kamel Laribi, Alix Baugier de Materre, Mohamad Sobh, et al.
Blood Advances (2020) Vol. 4, Iss. 19, pp. 4838-4848
Open Access | Times Cited: 58
Sex-BiasedZRSR2Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis
Katsuhiro Togami, Sun Sook Chung, Vikas Madan, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 522-541
Open Access | Times Cited: 46
Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients
Mahsa Khanlari, C. Cameron Yin, Koichi Takahashi, et al.
Leukemia (2022) Vol. 36, Iss. 5, pp. 1343-1350
Closed Access | Times Cited: 37
Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells
Tianyu Cai, Agnès Gouble, Kathryn L. Black, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 32
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm
Naveen Pemmaraju, Kendra Sweet, Anthony S. Stein, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 26, pp. 3032-3036
Open Access | Times Cited: 32
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet, et al.
Blood (2022) Vol. 141, Iss. 6, pp. 567-578
Open Access | Times Cited: 31
Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD
Naveen Pemmaraju, Nathaniel R. Wilson, Guillermo Garcia‐Manero, et al.
Blood Advances (2022) Vol. 6, Iss. 10, pp. 3027-3035
Open Access | Times Cited: 30
In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent
Fanny Angelot‐Delettre, Anne Roggy, Arthur E. Frankel, et al.
Haematologica (2014) Vol. 100, Iss. 2, pp. 223-230
Open Access | Times Cited: 61
Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies
Kamel Laribi, Nathalie Denizon, Anne Besançon, et al.
Biology of Blood and Marrow Transplantation (2016) Vol. 22, Iss. 8, pp. 1357-1367
Open Access | Times Cited: 57
Blastic Plasmacytoid Dendritic Cell Neoplasm
Joseph D. Khoury
Current Hematologic Malignancy Reports (2018) Vol. 13, Iss. 6, pp. 477-483
Closed Access | Times Cited: 53
Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Literature Review
Marie JeongMin Kim, Ahmed Nasr, Bilaal Kabir, et al.
Journal of Pediatric Hematology/Oncology (2017) Vol. 39, Iss. 7, pp. 528-537
Closed Access | Times Cited: 53
T cells expressing CD123 chimeric antigen receptors for treatment of acute myeloid leukemia
Armen Mardiros, Stephen J. Forman, Lihua E. Budde
Current Opinion in Hematology (2015) Vol. 22, Iss. 6, pp. 484-488
Open Access | Times Cited: 52
Blastic Plasmacytoid Dendritic Cell Neoplasm–Current Insights
Sangeetha Venugopal, Selena Zhou, Siraj M. El Jamal, et al.
Clinical Lymphoma Myeloma & Leukemia (2019) Vol. 19, Iss. 9, pp. 545-554
Closed Access | Times Cited: 47
Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm
Sho Kubota, Kenji Tokunaga, Tomohiro Umezu, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 45
Central nervous system involvement in blastic plasmacytoid dendritic cell neoplasm
Naveen Pemmaraju, Nathaniel R. Wilson, Joseph D. Khoury, et al.
Blood (2021) Vol. 138, Iss. 15, pp. 1373-1377
Open Access | Times Cited: 41
Breakthrough in Blastic Plasmacytoid Dendritic Cell Neoplasm Cancer Therapy Owing to Precision Targeting of CD123
Serena Zanotta, Domenico Galati
(2024)
Open Access | Times Cited: 5
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Comprehensive Review of the Disease, Central Nervous System Presentations, and Treatment Strategies
Shefali Mehra, Justin Taylor
Cells (2024) Vol. 13, Iss. 3, pp. 243-243
Open Access | Times Cited: 5
Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients
Naveen Pemmaraju, Branko Cuglievan, Joseph A. Lasky, et al.
eJHaem (2024) Vol. 5, Iss. 1, pp. 61-69
Open Access | Times Cited: 5
Flow Cytometry Profiling of Plasmacytoid Dendritic Cell Neoplasms
Siba El Hussein, Wei Wang
Cancers (2024) Vol. 16, Iss. 11, pp. 2118-2118
Open Access | Times Cited: 5
First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases
Weili Sun, Huaying Liu, Young Kim, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 45
Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm
Laure Philippe, Adam Ceroi, Elodie Bôle‐Richard, et al.
Haematologica (2017) Vol. 102, Iss. 11, pp. 1861-1868
Open Access | Times Cited: 43
Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow
Alexandar Tzankov, Konnie M. Hebeda, Markus Kremer, et al.
Annals of Hematology (2017) Vol. 96, Iss. 5, pp. 765-777
Closed Access | Times Cited: 41

Scroll to top